Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019006283) AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/006283 International Application No.: PCT/US2018/040262
Publication Date: 03.01.2019 International Filing Date: 29.06.2018
IPC:
A61K 31/416 (2006.01) ,A61K 31/437 (2006.01) ,A61K 31/4375 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
415
1,2-Diazoles
416
condensed with carbocyclic ring systems, e.g. indazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
4375
the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
Applicants:
POWERS, Jay, Patrick [US/US]; US
BECK, Hilary, Plake [US/US]; US
OSIPOV, Maksim [US/US]; US
REILLY, Maureen, Kay [US/US]; US
SHUNATONA, Hunter, Paul [US/US]; US
WALKER, James, Ross [US/US]; US
ZIBINSKY, Mikhail [US/US]; US
ROSENBAUM, Tamar [US/US]; US
YOUNG, Ian, Scott [CA/US]; US
NELSON, Jennifer [US/US]; US
VLAHOVA, Petinka [US/US]; US
BRISTOL-MYERS SQUIBB COMPANY [US/US]; Route 206 & Province Line Road Princeton, NJ 08543, US
Inventors:
POWERS, Jay, Patrick; US
BECK, Hilary, Plake; US
OSIPOV, Maksim; US
REILLY, Maureen, Kay; US
SHUNATONA, Hunter, Paul; US
WALKER, James, Ross; US
ZIBINSKY, Mikhail; US
ROSENBAUM, Tamar; US
YOUNG, Ian, Scott; US
NELSON, Jennifer; US
VLAHOVA, Petinka; US
Agent:
LODISE, Stephanie, A.; US
Priority Data:
62/527,85530.06.2017US
Title (EN) AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS
(FR) FORMES AMORPHES ET CRISTALLINES D’INHIBITEURS DE L'IDO
Abstract:
(EN) The present disclosure relates to amorphous and crystalline forms of (R)-N-(4- chlorophenyl)-2-((lS,4S)-4-(6-fluoroquinolin-4-yl) cyclohexyl)propanamide and its salts and hydrates, processes for their production, pharmaceutical compositions comprising them, and methods of treatment using them.
(FR) La présente invention concerne des formes amorphes et cristallines de (R)-N-(4- chlorophényl)-2-((lS,4S)-4-(6-fluoroquinolin-4-yl) cyclohéxyl)propanamide et ses sels et hydrates, des procédés pour leur production, des compositions pharmaceutiques les comprenant, et des procédés de traitement les utilisant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)